Bronchopulmonary Dysplasia clinical trials

Explore recruiting bronchopulmonary dysplasia clinical trials.

Recruiting bronchopulmonary dysplasia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bronchopulmonary Dysplasia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The effect of additional pre-extubational loading dose of caffeine-citrate

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

Phase I single arm, dose escalating and phase II double blind, randomized, placebo-controlled dose finding clinical trial assessing safety, and efficacy of intratracheal administration of allogeneic umbilical mesenchymal cells-derived extracellular vesicles in preventing bronchopulmonary dysplasia in extremely preterm newborns.

Italy, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Does the Use of Higher Versus Lower Oxygen Concentration Improve Neurodevelopmental Outcomes at 24 Months (plus or minus 6 months) in Very Low Birthweight Infants: The HiLo-Trial

Ireland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2a, Open-label, Single-Arm Study Investigating Tolerability of IV/IM Administration of RetinolX (retinol palmitate) in Preterm Infants, and Measuring Serum Levels of Retinol, Retinol Palmitate and Retinol Binding Protein (RBP4) (PARELETO - Trial)

Poland, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Echec-MAT - A combination of antibiotics to improve neonatal mortality and morbidity for pregnancies complicated with previable labour and intact membranes: an open multiple center, randomized, and controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, Double-Blind, Parallel-Group, Adaptive, Three-arm, Phase 2b/3 Multicenter Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preventing Bronchopulmonary Dysplasia (BPD) in High-Risk Preterm Neonates Compared to Standard of Care (SOC)

Italy, Spain, Belgium, France, Germany, Poland +2 more

Phase II and Phase III (Integrated) EU CTIS Study details

Bronchopulmonary Dysplasia trials by city

Bronchopulmonary Dysplasia in Toronto Bronchopulmonary Dysplasia in Vancouver Bronchopulmonary Dysplasia in Montreal Bronchopulmonary Dysplasia in Calgary Bronchopulmonary Dysplasia in Edmonton Bronchopulmonary Dysplasia in Ottawa Bronchopulmonary Dysplasia in Winnipeg Bronchopulmonary Dysplasia in Quebec City Bronchopulmonary Dysplasia in Hamilton Bronchopulmonary Dysplasia in Kitchener Bronchopulmonary Dysplasia in London Bronchopulmonary Dysplasia in Halifax Bronchopulmonary Dysplasia in New York Bronchopulmonary Dysplasia in Los Angeles Bronchopulmonary Dysplasia in Chicago Bronchopulmonary Dysplasia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease